Fiasp FlexTouch 100 IU/ml (SC Injection)

3 ml pen: ৳ 950.00 (5's pack: ৳ 4,750.00)

Medicine Details

Category Details
Generic Insulin aspart
Company Novo nordisk pharma pvt ltd

Indications

  • Improves glycemic control in adults and children with diabetes mellitus

Composition

  • 100 IU (equivalent to 3.50 mg) Insulin Aspart (rDNA) BP as 30% soluble Insulin Aspart and 70% protamine-crystallised Insulin Aspart per ml suspension

Description

  • Sterile suspension of human insulin analog
  • Contains 30% soluble Fiasp FlexTouch and 70% protamine-crystallised Fiasp FlexTouch
  • Blood glucose lowering agent with early onset and intermediate duration of action
  • Produced by recombinant DNA technology

Pharmacology

  • Regulates glucose metabolism by binding to insulin receptors on muscle and fat cells

Dosage

  • Individual dosage determined by physician
  • Can be given in mono therapy or in combination with oral antidiabetic drugs
  • Recommended starting dose for type 2 diabetes is 6 IU at breakfast and 6 IU at dinner
  • Initial once daily dose is 12 IU at dinner, can increase to twice-daily if needed
  • Dose adjustments can be made once a week until target HbA1c is reached
  • Individual insulin requirement for type 1 diabetes is usually between 0.5 and 1.0 IU/kg/day

Administration

  • Administer 5-10 minutes before meal

Interaction

  • Certain drugs may reduce or increase Fiasp FlexTouch requirements
  • Substances like oral anti-diabetic products, angiotensin converting enzyme (ACE) inhibitors, and more may affect requirements

Contraindications

  • Not to be used during episodes of hypoglycemia or in patients with hypersensitivity to Insulin Aspart or its excipients

Side Effects

  • Hypoglycemia, allergic reactions, injection site reaction, lipodystrophy, pruritus, rash

Pregnancy & Lactation

  • Pregnancy category B, no restrictions on treatment during lactation

Precautions & Warnings

  • Blood glucose monitoring, cautious modification of regimens under medical supervision

Use in Special Populations

  • Decreased dose may be necessary in case of renal or hepatic impairment

Overdose Effects

  • Hypoglycemia may develop if too high doses are administered
  • Mild hypoglycaemic episodes can be treated by oral administration of glucose or sugary products
  • Severe hypoglycaemic episodes treated by glucagon (0.5 to 1 mg) and intravenous glucose

Therapeutic Class

  • Rapid Acting Insulin

Storage Conditions

  • Store at 2°C to 8°C in a refrigerator, protect from light

Related Brands